Clinical Trials Logo

Clinical Trial Summary

The study has been designed as a prospective randomized clinical trial. Due to the use of a bispectral (BIS) monitor in the interventional arm, the study will not be blinded for the anesthetist. The total planned number of study subjects is 100. Patients will be randomly randomized upon arrival to the operating theatre (using the envelope method) into the interventional arm (BIS monitoring of the depth of general anesthesia), and into the control group (standard management of general anesthesia to minimum alveolar concentration (MAC) 1,0). The target values of the depth of general anesthesia according to BIS are between 40 and 60.


Clinical Trial Description

The condition of postoperative nausea and vomiting (PONV) is defined as nausea and vomiting, which appears within 24 hours after the performance of a surgical/diagnostic procedure in general anesthesia. PONV is perceived as a complication of minor importance in perioperative medicine, nevertheless, it is one of the most frequent causes of morbidity in pediatric patients in the early postoperative period, associated with a number of adverse effects. The incidence of PONV in pediatric age is reported in scientific literature to be between 8.9 and 42 percent. The pathogenesis of PONV is complex and has not been fully clarified yet. The development of PONV depends on individual and anaesthesiology risk factors, and the type of surgical procedure. The use of inhalation anesthetics demonstrably increases the incidence of PONV, especially in the course of the first two hours after the procedure. The need for inhalation anesthetic is individually variable, and it is not possible to empirically define, which dose will lead to an adequate depth of anesthesia. Excessively deep, as well as too shallow anesthesia may result in increasing the incidence of postoperative complications, including PONV. The depth of anesthesia and unconsciousness may be monitored with BIS (bispectral index). The investigators presume that optimization of the supply of inhalation anesthetic according to BIS, so-called BIGA (Bispectral index guided anesthesia) will lead to decreasing the incidence of PONV. Several clinical studies performed on the adult population have demonstrated that using BIGA leads to a decreased incidence of PONV in adult patients undergoing gynecological procedures. As far as pediatric anesthesiology is concerned, similar studies are still lacking. Inhalation anesthesia is also associated with another complication in the early postoperative period - so-called emergence delirium (ED). It is a condition of psychomotor restlessness, perception disorders, and excitation of the child observed after completion of anesthesia. The incidence of ED in the pediatric population anesthesia is between 10 and 80 percent, most frequently within the first 10-30 minutes after discontinuation of the administration of anesthetics. The condition is characterized by confusion, loss of orientation, crying, restlessness, and non-cooperation of the child. The causes of ED have not been fully clarified. One of the possible causes may be the rapid emergence of the child from anesthesia after discontinuation of the inhalation anesthetic. The incidence of ED is highest with Sevoflurane, which is the most frequently used inhalation anesthetic in pediatric anesthesia. Optimization of the depth of general anesthesia and decreasing the consumption of inhalation anesthetic may lead to decreasing the incidence of emergence delirium objectified according to the Paediatric Anaesthesia Emergence Delirium (PAED) score. The study has been designed as a prospective randomized clinical trial. Due to the use of the BIS monitor in the interventional arm, the study will not be blinded for the anesthetist. The total planned number of study subjects is 100. Patients will be randomly randomized upon arrival to the operating theatre (using the envelope method) into the interventional arm (BIS monitoring of the depth of general anesthesia), and into the control group (standard management of general anesthesia to minimum alveolar concentration (MAC) of 1.0). The target values of the depth of general anesthesia according to BIS are between 40 and 60. General anesthesia will be administered according to the following uniform anaesthesiology protocol: Inhalation introduction with Sevoflurane (8% on the vaporizer), in a carrier mixture of gases oxygen : air, with the flow of 41/min and oxygen concentration of 50%. In the intervention group, BIS will be introduced as soon as possible. After achieving a sufficient depth of anesthesia, a peripheral venous catheter will be introduced, followed with intravenous administration of opioid - Sufentanil in the dose of 0.2ucg/kg, and intravenous administration of Paracetamol in the dose of 15mg/kg. The infusion will be administered in the course of the surgical procedure - isotonic crystalloid solution Benelyte in the dose of 10ml/kg/hour. Breathing passageways will be secured with an armed laryngeal mask, according to the standard procedure applied at the author's center. Considering the character of the study, no antiemetic prophylaxis will be administered. After completion of the surgical procedure and emergence from general anesthesia, the child will be transferred to post-anesthesia care unit (PACU), where, apart from the monitoring of vital functions, also the incidence of PONV and the PAED score (in the 10th minute, 30th minute, and 60th minute) will be observed. At the Ear-Nose-Throat (ENT) department, the authors will record the Baxter Retching Faces (BARF) scale in pre-determined time intervals, and the incidence of PONV in the course of the whole hospitalization. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04466579
Study type Interventional
Source University Hospital Ostrava
Contact
Status Completed
Phase N/A
Start date July 1, 2020
Completion date June 30, 2023

See also
  Status Clinical Trial Phase
Completed NCT03787849 - Epigenetics in PostOperative Pediatric Emergence Delirium N/A
Completed NCT03788564 - The Association of Cardiac Ion Channel Related Gene Polymorphism and Prolonged QTc Interval After Endotracheal Intubation
Recruiting NCT01221025 - Effect Study of Parecoxib to Treat Emergence Delirium and Postoperative Pain Phase 4
Not yet recruiting NCT06035757 - The Occurrence of Emergence Agitation in Pediatric Strabismus Surgery Phase 4
Not yet recruiting NCT04291820 - Impact of Anaesthesiology Management on Paediatric Emergence Delirium Incidence N/A
Completed NCT05124067 - Effect of Dexmedetomidine on Prevention of Postoperative Nausea and Vomiting in Children Phase 1
Recruiting NCT05091242 - The PREVENT AGITATION Trial II - Children ≤1 Year Phase 2/Phase 3
Completed NCT03330236 - EEG - Guided Anesthetic Care and Postoperative Delirium N/A
Completed NCT04531020 - Incidence of Emergence Delirium in the PACU
Completed NCT05105178 - Verbal Stimulation of Orientation on Emergence Agitation N/A
Completed NCT03285243 - Effect of Monochromatic Light on Incidence of Emergence Delirium in Children N/A
Recruiting NCT04621305 - Remimazolam Reduces Emergence Delirium in Preschool Children Undergoing Laparoscopic Surgery by Sevoflurane Anesthesia Phase 4
Completed NCT01096797 - Correlation Between Pain and Emergence Delirium After Adenotonsillectomy in Preschool Children Phase 4
Recruiting NCT03330613 - Emergence Delirium and Recovery Time in Children N/A
Completed NCT05872087 - Comparative Study Between Nebulised Dexmedetomidine and Nebulised Midazolam in Children Undergoing Lower Abdominal Surgeries Phase 1
Recruiting NCT06326983 - Opioid Sparing Anesthesia Care for Pediatric Patients Having Tonsil Surgery N/A
Not yet recruiting NCT06387953 - Mitigation of Emergence Agitation Through Implementation of Masimo Bridge Therapy N/A
Not yet recruiting NCT06406257 - Temperature Management on Postoperative Delirium N/A
Not yet recruiting NCT05883280 - The Effect of Binaural Sound on the Occurrence of Emergence Delirium in Children Undergoing Strabismus Surgery N/A
Not yet recruiting NCT05821972 - Nebulized Dexmedetomidine Combined With Ketamine Versus Nebulized Dexmedetomidine for Cleft Palate Phase 4